However, the data obtained to date consistently indicate that miR-122 is downregulated in patients with HBV-associated HCC and related to tumor size, lymph node metastasis, TNM stage, pathological type, differentiation grade, liver cirrhosis, AFP, and HBV DNA [30,31]. Here, AFP is linked to hepatocellular carcinoma.